285 related articles for article (PubMed ID: 26876436)
1. Preventive effect of sildenafil on right ventricular function in rats with monocrotaline-induced pulmonary arterial hypertension.
Yoshiyuki R; Tanaka R; Fukushima R; Machida N
Exp Anim; 2016 Jul; 65(3):215-22. PubMed ID: 26876436
[TBL] [Abstract][Full Text] [Related]
2. Comparison of preventive effect of sildenafil and therapeutic effect of sildenafil treatment in rats with monocrotaline-induced pulmonary arterial hypertension.
Yoshiyuki R; Fukushima R; Tanaka R; Machida N
J Vet Med Sci; 2016 Nov; 78(10):1607-1610. PubMed ID: 27320637
[TBL] [Abstract][Full Text] [Related]
3. Pimobendan improves right ventricular myocardial contraction and attenuates pulmonary arterial hypertension in rats with monocrotaline-induced pulmonary arterial hypertension.
Yoshiyuki R; Nakata TM; Fukayama T; Hamabe L; Huai-Che H; Suzuki S; Machida N; Fukushima R; Tanaka R
J Med Ultrason (2001); 2014 Apr; 41(2):173-80. PubMed ID: 27277770
[TBL] [Abstract][Full Text] [Related]
4. Effects of Single Drug and Combined Short-term Administration of Sildenafil, Pimobendan, and Nicorandil on Right Ventricular Function in Rats With Monocrotaline-induced Pulmonary Hypertension.
Nakata TM; Tanaka R; Yoshiyuki R; Fukayama T; Goya S; Fukushima R
J Cardiovasc Pharmacol; 2015 Jun; 65(6):640-8. PubMed ID: 25806612
[TBL] [Abstract][Full Text] [Related]
5. Urantide improves the structure and function of right ventricle as determined by echocardiography in monocrotaline-induced pulmonary hypertension rat model.
Wang Y; Tian W; Xiu C; Yan M; Wang S; Mei Y
Clin Rheumatol; 2019 Jan; 38(1):29-35. PubMed ID: 29362961
[TBL] [Abstract][Full Text] [Related]
6. Synergistic interaction between a PDE5 inhibitor (sildenafil) and a new adenosine A2A receptor agonist (LASSBio-1359) improves pulmonary hypertension in rats.
Alencar AK; Carvalho FI; Silva AM; Martinez ST; Calasans-Maia JA; Fraga CM; Barreiro EJ; Zapata-Sudo G; Sudo RT
PLoS One; 2018; 13(4):e0195047. PubMed ID: 29677206
[TBL] [Abstract][Full Text] [Related]
7. Glycyrrhizin, inhibitor of high mobility group box-1, attenuates monocrotaline-induced pulmonary hypertension and vascular remodeling in rats.
Yang PS; Kim DH; Lee YJ; Lee SE; Kang WJ; Chang HJ; Shin JS
Respir Res; 2014 Nov; 15():148. PubMed ID: 25420924
[TBL] [Abstract][Full Text] [Related]
8. Beneficial effects of aqueous extract of stem bark of Terminalia arjuna (Roxb.), An ayurvedic drug in experimental pulmonary hypertension.
Meghwani H; Prabhakar P; Mohammed SA; Seth S; Hote MP; Banerjee SK; Arava S; Ray R; Maulik SK
J Ethnopharmacol; 2017 Feb; 197():184-194. PubMed ID: 27401289
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of the effects of RP5063, a novel, multimodal, serotonin receptor modulator, as single-agent therapy and co-administrated with sildenafil, bosentan, and treprostinil in a monocrotaline-induced pulmonary arterial hypertension rat model.
Bhat L; Hawkinson J; Cantillon M; Reddy DG; Bhat SR; Laurent CE; Bouchard A; Biernat M; Salvail D
Eur J Pharmacol; 2018 May; 827():159-166. PubMed ID: 29453947
[TBL] [Abstract][Full Text] [Related]
10. 17β-estradiol preserves right ventricular function in rats with pulmonary arterial hypertension: an echocardiographic and histochemical study.
Wang YD; Li YD; Ding XY; Wu XP; Li C; Guo DC; Shi YP; Lu XZ
Int J Cardiovasc Imaging; 2019 Mar; 35(3):441-450. PubMed ID: 30350115
[TBL] [Abstract][Full Text] [Related]
11. Progesterone inhibits vascular remodeling and attenuates monocrotaline-induced pulmonary hypertension in estrogen-deficient rats.
Tofovic PS; Zhang X; Petrusevska G
Prilozi; 2009 Jul; 30(1):25-44. PubMed ID: 19736529
[TBL] [Abstract][Full Text] [Related]
12. Assessment of the endothelial functions in monocrotaline-induced pulmonary hypertension.
Sirmagul B; Ilgin S; Atli O; Usanmaz SE; Demirel-Yilmaz E
Clin Exp Hypertens; 2013; 35(3):220-7. PubMed ID: 22967272
[TBL] [Abstract][Full Text] [Related]
13. Fasudil reduces monocrotaline-induced pulmonary arterial hypertension: comparison with bosentan and sildenafil.
Mouchaers KT; Schalij I; de Boer MA; Postmus PE; van Hinsbergh VW; van Nieuw Amerongen GP; Vonk Noordegraaf A; van der Laarse WJ
Eur Respir J; 2010 Oct; 36(4):800-7. PubMed ID: 20351034
[TBL] [Abstract][Full Text] [Related]
14. 2-Methoxyestradiol mediates the protective effects of estradiol in monocrotaline-induced pulmonary hypertension.
Tofovic SP; Zhang X; Jackson EK; Dacic S; Petrusevska G
Vascul Pharmacol; 2006 Dec; 45(6):358-67. PubMed ID: 16872912
[TBL] [Abstract][Full Text] [Related]
15. Early Intervention of Tongxinluo () on Right Ventricular Function Assessed by Echocardiography in Rats with Pulmonary Arterial Hypertension Induced by Monocrotaline.
Gao L; Li SD; Zhang Y; Liu Y; Yang MH
Chin J Integr Med; 2020 Dec; 26(12):913-920. PubMed ID: 32418178
[TBL] [Abstract][Full Text] [Related]
16. Sulforaphane Improves Redox Homeostasis and Right Ventricular Contractility in a Model of Pulmonary Hypertension.
Conzatti A; Colombo R; Siqueira R; Campos-Carraro C; Turck P; Luz de Castro A; Belló-Klein A; Sander da Rosa Araujo A
J Cardiovasc Pharmacol; 2024 Jun; 83(6):612-620. PubMed ID: 38547510
[TBL] [Abstract][Full Text] [Related]
17. Percutaneous Carbon Dioxide Treatment Using a Gas Mist Generator Attenuates the Development of Right Ventricular Dysfunction in Monocrotaline-induced Pulmonary Hypertensive Rats.
Yamaguchi T; Izumi Y; Yamazaki T; Nakamura Y; Sano S; Shiota M; Miura K; Iwao H; Yoshiyama M
Osaka City Med J; 2015 Jun; 61(1):31-41. PubMed ID: 26434103
[TBL] [Abstract][Full Text] [Related]
18. Pulmonary hemodynamic response to acute combination and monotherapy with sildenafil and brain natriuretic peptide in rats with monocrotaline-induced pulmonary hypertension.
Carlino C; Tobias JD; Schneider RI; Heller RL; Alpert MA; Grueber RE; Dellsperger KC; Demarco VG
Am J Med Sci; 2010 Jan; 339(1):55-9. PubMed ID: 19996941
[TBL] [Abstract][Full Text] [Related]
19. Oral sildenafil prevents and reverses the development of pulmonary hypertension in monocrotaline-treated rats.
Liu H; Liu ZY; Guan Q
Interact Cardiovasc Thorac Surg; 2007 Oct; 6(5):608-13. PubMed ID: 17670742
[TBL] [Abstract][Full Text] [Related]
20. Heart rate reduction improves biventricular function and interactions in experimental pulmonary hypertension.
Gomez O; Okumura K; Honjo O; Sun M; Ishii R; Bijnens B; Friedberg MK
Am J Physiol Heart Circ Physiol; 2018 Mar; 314(3):H542-H551. PubMed ID: 29146614
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
